SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-028351
Filing Date
2024-12-04
Accepted
2024-12-04 21:45:05
Documents
1
Period of Report
2024-12-02

Document Format Files

Seq Description Document Type Size
1 form4-12042024_091201.html 4  
1 form4-12042024_091201.xml 4 16275
  Complete submission text file 0001415889-24-028351.txt   17832
Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Issuer) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARS PHARMACEUTICALS, INC. 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address
Chakma Justin (Reporting) CIK: 0001951238 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39756 | Film No.: 241527645